Tenaya Therapeutics Faces Delisting Concerns
Ticker: TNYA · Form: 8-K · Filed: Apr 18, 2025
Sentiment: bearish
Topics: delisting, listing-standards, regulatory-filing
TL;DR
Tenaya's in hot water with the exchange, might get delisted.
AI Summary
Tenaya Therapeutics, Inc. filed an 8-K on April 18, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, with the earliest event reported on April 15, 2025. The company is incorporated in Delaware and its principal executive offices are located at 171 Oyster Point Boulevard, Suite 500, South San Francisco, California.
Why It Matters
This filing indicates potential issues with Tenaya Therapeutics' continued listing on an exchange, which could significantly impact its stock value and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's market presence and stock valuation.
Key Numbers
- 001-40656 — SEC File Number (Identifies the company's filing history with the SEC.)
- 81-3789973 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Tenaya Therapeutics, Inc. (company) — Registrant
- April 15, 2025 (date) — Earliest event reported
- April 18, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- 171 Oyster Point Boulevard, Suite 500, South San Francisco, California (location) — Principal executive offices
FAQ
What specific listing rule or standard has Tenaya Therapeutics failed to satisfy?
The filing does not specify the exact rule or standard that Tenaya Therapeutics has failed to satisfy, only that a notice has been issued.
What is the earliest date of the event reported in this 8-K?
The earliest event reported is dated April 15, 2025.
When was this 8-K form filed with the SEC?
This 8-K form was filed on April 18, 2025.
Where are Tenaya Therapeutics' principal executive offices located?
Tenaya Therapeutics, Inc.'s principal executive offices are located at 171 Oyster Point Boulevard, Suite 500, South San Francisco, California.
What is the company's state of incorporation?
Tenaya Therapeutics, Inc. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 18, 2025 regarding Tenaya Therapeutics, Inc. (TNYA).